Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Oligodendroglioma 1Glioma 1Glioblastoma 1Brain Neoplasms 1Astrocytoma 1

Interventions

Temozolomide 7Radiotherapy 5Vincristine 3Cisplatin 3Carmustine 3Carboplatin 3Methotrexate 2Cyclophosphamide 2Chlorotoxin 2lonafarnib 1Verteporfin 1Thiotepa 1Surgical Procedures, Operative 1Peripheral Blood Stem Cell Transplantation 1Pemetrexed 1Metabolism 1In Situ Hybridization, Fluorescence 1Immunohistochemistry 1Gelclair 1Etoposide 1Ethanol 1Arsenic Trioxide 1Aminolevulinic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Oligodendroglioma × Metabolism × Clear all
NCT00591058 2009-07-17

Safety and Dose-Finding Study of TM-601 in Adults With Recurrent Malignant Glioma

TransMolecular

Phase 1 Unknown
36 enrolled
CNS

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡